Acute methotrexate neurotoxicity: findings on diffusion-weighted imaging and correlation with clinical outcome

Nancy Rollins1, Naomi Winick, Robert Bash

  • 1Department of Pediatric Radiology, University of Texas Southwestern Medical Center and Children's Medical Center of Dallas, 1935 Motor St., Dallas, TX 75235, USA.

Abstract

Insights

Diffusion MRI can detect acute neurotoxicity from methotrexate (MTX) in children with acute lymphocytic leukemia (ALL). These diffusion abnormalities indicate cerebral dysfunction, not necessarily permanent structural injury, guiding treatment decisions.

Area of Science:

  • Pediatric Oncology
  • Neuroradiology
  • Neuroscience

Background:

  • Acute lymphocytic leukemia (ALL) is a common childhood cancer.
  • Methotrexate (MTX) is a standard ALL treatment but can cause neurotoxicity.
  • Understanding MTX neurotoxicity is crucial for managing pediatric cancer patients.

Purpose of the Study:

  • To evaluate diffusion-weighted (DW) and conventional MRI findings in children with ALL experiencing acute MTX-induced neurotoxicity.
  • To correlate imaging findings with clinical presentation and neurological outcomes.
  • To assess the implications of imaging findings for ongoing chemotherapy.

Main Methods:

  • Five pediatric patients (aged 12-15) with ALL and suspected MTX neurotoxicity underwent MRI, including DW imaging, within 24 hours of symptom onset.
  • Conventional MRI sequences (FLAIR, T2, T1-gadolinium) were also performed.
  • Clinical data, including MTX administration timing, symptoms, and outcomes, were reviewed.

Main Results:

  • Six strokelike events were linked to intrathecal MTX administration.
  • Diffusion abnormalities were observed in the frontoparietal or frontal lobes, correlating with neurological deficits like aphasia and hemiparesis.
  • FLAIR imaging showed limited abnormalities; diffusion abnormalities indicated cerebral dysfunction without overt structural damage.

Conclusions:

  • Diffusion abnormalities on MRI are sensitive indicators of acute MTX neurotoxicity in children with ALL.
  • These findings suggest cerebral dysfunction rather than irreversible structural injury.
  • A single episode of neurotoxicity with diffusion abnormalities may not necessitate altering curative chemotherapy regimens.